Pharmacokinetics of nicotine delivered by a novel electronic nicotine delivery system in healthy adult smokers: a feasibility study

Ditch Labs is a medical technology company developing a new treatment for smoking cessation. The objective of this research project is to understand how nicotine delivered by a novel electronic nicotine deliver system travels through the body from its absorption to its excretion. The study is important because it will allow Ditch Labs to select optimal nicotine doses to be delivered to patients and then subsequently reduced over a period of several weeks until complete cessation.

Intern: 
Mehdi El Hassani
Superviseur universitaire: 
Amélie Marsot
Province: 
Quebec
Partenaire: 
Secteur: 
Partner University: 
Programme: